Background: The purpose of this study was to describe as well as compare our surgical treatment experiences of solid pseudopapillary neoplasms (SPN) of the pancreas and to provide a review of the literature. Methods: A retrospective analysis of data from Vilnius University Hospital Santariskiu Klinikos (VUH SK) and of the literature, which was researched using Karger Publishers, Springer Science, BioMed Central, and disserCat databases, was conducted. Results: From 2001 to 2012, seven cases were identified with pathologically confirmed SPN diagnosis. A precise preoperative diagnosis was made by computertomography and magnetic resonance imaging. The median diameter of the tumors was 6.36 cm (range 1.5-12 cm). Surgical treatment was undertaken for all patients. Results of the immunohistochemical analysis confirmed a nuclear accumulation of β-catenin. The Ki-67 level was 1-2% in all of the cases. According to our collected data, all types of histological analysis revealed decent prognostic behavior with low mitotic activity (1-2 mitoses per 50 high power fields). Besides, angioinvasion, perineural invasion, and outside capsule invasion were not detected. Conclusions: There was no correlation between more aggressive types of SPN and tumor size, localization, age, and gender.

Keywords:
Solid pseudopapillary neoplasm, Pancreas, Surgical treatment
1.
Frantz VK: Tumors of the pancreas; in Armed Forces Institute of Pathology: Atlas of Tumor Pathology. Washington DC, Armed Forces Institute of Pathology, 1959, pp 32-33.
2.
Kloppel G, Solcia E, Longnecker DS, Capella C, Sobin LH: Histological typing of tumors of the exocrine pancreas; in World Health Organization: International Histological Classification of Tumors, ed 2. New York, Springer, 1996, pp 15-21.
3.
Kloppel G, Luttges J, Klimstra DS: Solid-pseudopapillary neoplasm; in Hamilton SR, Aaltonene LA (eds): World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Digestive System. Lyon, IARC, 2000, pp 246-248.
4.
Allen P, D'Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, DeMatteo R, Fong Y, Blumgart LH, Brennan MF: A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 2006;244:572-582.
5.
Adams AL, Siegal GP, Jhala NC: Solid pseudopapillary tumor of the pancreas. A review of salient clinical and pathologic features. Adv Anat Pathol 2008;15:572-582.
6.
Lam KY, Lo CY, Asanuma K, Fan ST: Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg 1999;23:1045-1050.
7.
Papavramidis T, Papavramidis S: Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg 2005;200:965-972.
8.
Geers C, Moulin P, Gigot JF, Weynand B, Deprez P, Rahier J, Sempoux C: Solid and pseudopapillary tumor of the pancreas - review and new insights into pathogenesis. Am J Surg Pathol 2006;30:1243-1249.
9.
Lin MY, Stabile BE: Solid pseudopapillary neoplasm of the pancreas: a rare and atypically aggressive disease among male patients. Am Surg 2010; 76:1075-1078.
10.
Tanaka Y, Kato K, Notohara K, Hojo H, Ijiri R, Miyake T, Nagahara N, Sasaki F, Kitagawa N, Nakatani Y, Kobayashi Y: Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 2001;61:8401-8404.
11.
Baum B, Georgiou M: Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol 2011;192:907-917.
12.
Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-480.
13.
Park M, Kim M, Hwang D, Park M, Kim WK, Kim SK, Shin J, Park ES, Kang CM, Paik YK, Kim H: Characterization of gene expression and activated signaling pathways in solid-pseudopapillary neoplasm of pancreas. Mod Pathol Online 2013;10:154-161.
14.
Yu PF, Hu ZH, Wang XB, Guo JM, Cheng XD, Zhang YL, Xu Q: Solid pseudopapillary tumor of the pancreas: a review of 553 cases in Chinese literature. World J Gastroenterol 2010;16:1209-1214.
15.
Reddy S, Cameron JL, Scudiere J, Hruban RH, Fishman EK, Ahuja N, Pawlik TM, Edil BH, Schulick RD, Wolfgang CL: Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series. J Am Coll Surg 2009;208:950-959.
16.
Raman SP, Kawamoto S, Law JK, Blackford A, Lennon AM, Wolfgang CL, Hruban RH, Cameron JL, Fishman EK: Institutional experience with solid pseudopapillary neoplasms: focus on computed tomography, magnetic resonance imaging, conventional ultrasound, endoscopic ultrasound, and predictors of aggressive histology. J Comput Assist Tomogr 2013;37:824-833.
17.
Machado MC, Machado MA, Bacchella T, Jukemura J, Almeida JL, Cunha JE: Solid pseudopapillary neoplasm of the pancreas: distinct patterns of onset, diagnosis, and prognosis for male versus female patients. Surgery 2008;143:29-34.
18.
Yin Q, Wang M, Wang C, Wu Z, Yuan F, Chen K, Tang Y, Zhao X, Miao F: Differentiation between benign and malignant solid pseudopapillary tumor of the pancreas by MDCT. Eur J Radiol 2012;81: 3010-3018.
19.
Zhao P, Debrito P, Ozdemirli M, Sidawy MK: Solid-pseudopapillary neoplasm of the pancreas: awareness of unusual clinical presentations and morphology of the clear cell variant can prevent diagnostic errors. Diagn Cytopathol 2013;41:889-895.
20.
Pettinato G, Manivel JC, Ravetto C, Terracciano LM, Gould EW, di Tuoro A, Jaszcz W, Albores-Saavedra J: Papillary cystic tumor of the pancreas. A clinicopathologic study of 20 cases with cytologic, immunohistochemical, ultrastructural and flow cytometric observations and a review of the literature. Am J Clin Pathol 1992;98:478-488.
21.
Serra S, Chetty R: Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumour of the pancreas. J Clin Pathol 2008;61:1153-1159.
22.
Morikawa T, Onogawa T, Maeda S, Takadate T, Shirasaki K, Yoshida H, Ishida K, Motoi F, Naitoh T, Rikiyama T, Katayose Y, Egawa S, Unno M: Solid pseudopapillary neoplasms of the pancreas: an 18-year experience at a single Japanese Institution. Surg Today 2013;43:26-32.
23.
Vassos N, Agaimy A, Klein P, Hohenberger W, Croner RS: Solid-pseudopapillary neoplasm (SPN) of the pancreas: case series and literature review on an enigmatic entity. Int J Clin Exp Pathol 2013;6: 1051-1059.
24.
Martin RC, Klimstra DS, Brennan MF, Conlon KC: Solid-pseudopapillary tumor of pancreas: a surgical enigma? Ann Surg Oncol 2002;9:35-40.
25.
Yoon DY, Hines OJ, Bilchik AJ, Lewin K, Cortina G, Reber HA: Solid and papillary epithelial neoplasms of the pancreas: aggressive resection for cure. Am Surg 2001;67:1195-1199.
26.
Vollmer CM, Dixon W, Grant DR: Management of a solid pseudopapillary tumor of the pancreas with liver metastases. HPB (Oxford) 2003;5:264-267.
27.
Das G, Bhuyan C, Das BK, Sharma JD, Saikia BJ, Purkystha J: Spleen-preserving distal pancreatictomy following neoadjuvant chemotherapy for papillary solid and cystic neoplasm of pancreas. Ind J Gastroenterology 2004;23:188-189.
28.
Matsunou H, Konishi F: Papillary-cystic neoplasm of the pancreas: a clinicopathologic study concerning the tumor aging and malignancy of nine cases. Cancer 1990;65:283-291.
29.
Tang LH, Aydin H, Brennan MF, Klinstra DS: Clinically aggressive solid pseudopapillary tumor of pancreas: a report of cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol 2005;29:512-519.
© 2014 S. Karger GmbH, Freiburg
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.